News Daily News Coverage and Use of Impella and Watchman: A Tale of Four Countries Michael O'Riordan March 04, 2025
News Daily News Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity L.A. McKeown December 23, 2024
News Daily News Scientific Statement Reviews Current Antithrombotic Options in PAD L.A. McKeown August 26, 2024
News Daily News Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients L.A. McKeown June 29, 2022
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA Yael L. Maxwell April 29, 2021
News Daily News P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention Yael L. Maxwell May 15, 2020
News Daily News Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS Caitlin E. Cox September 20, 2019
News Daily News IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease L.A. McKeown January 25, 2019
News Daily News CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition Michael O'Riordan August 04, 2017
News Daily News Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats L.A. McKeown May 03, 2017
News Daily News Evidence Supporting Percutaneous or Surgical LAA Exclusion for Stroke Prevention Is Limited, Review Says Todd Neale July 14, 2016
News Daily News El Tratamiento Antiplaquetario Doble se asoció a Mejores Resultados en Pacientes EAP de Alto Riesgo Leah Lawrence April 29, 2015
News Daily News Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients Leah Lawrence April 29, 2015
News Daily News Risk Score for Critical Limb Ischemia Identifies Patients with Poor Prognosis December 29, 2014
News Daily News High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures Yael L. Maxwell April 26, 2013